ロード中...
Early erythropoiesis‐stimulating agents in preterm or low birth weight infants
BACKGROUND: Preterm infants have low plasma levels of erythropoietin (EPO), providing a rationale for the use of erythropoiesis‐stimulating agents (ESAs) to prevent or treat anaemia and to provide neuro protection and protection against necrotising enterocolitis (NEC). Darbepoetin (Darbe) and EPO ar...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2020
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7014351/ https://ncbi.nlm.nih.gov/pubmed/32048730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004863.pub6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|